Cite

HARVARD Citation

    Mitchell, R. et al. (n.d.). Use of the 13-valent pneumococcal conjugate vaccine in children and adolescents aged 6 – 17 years. Expert opinion on biological therapy. pp. 1451-1465. [Online]. 
  
Back to record